NIH-funded research R01 grant

T Lymphopenia After a Heart Attack: Could Restoring T Cells Help Your Heart Heal

Official title: T Lymphopenia in Ischemic Heart Failure

Funded at University of South Florida · NIH-11550873 · Data updated 2026-11-12

A study at the University of South Florida aims to understand why certain immune cells called CD4+ T cells drop after a heart attack and whether boosting them could improve heart recovery.

More Heart Failure research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of South Florida
NIH-funded
Lab location1 site (Tampa, United States)
Project startJuly 1, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$83,700
NIH project number3R01HL164446-04S1
Project IDNIH-11550873 on NIH RePORTER

Who could benefit from this research

Could help

Patients who have experienced a myocardial infarction and are at risk for or developing heart failure.

Less likely to help

This study is conducted in animals to understand mechanisms, so direct benefit to patients during the study may be limited.

What this research studies

This project uses a mouse model of heart failure after a heart attack to explore how T lymphocytes move from the blood to the bone marrow and how their development might be impaired. The researchers will test whether preventing CD4+ T-cell loss could support better healing of heart tissue after an infarction. By uncovering the mechanisms behind T lymphopenia, they hope to identify potential therapeutic targets to improve long-term outcomes for patients who have had a heart attack.

Why it matters

Potential benefit: If successful, this work could lead to new strategies that support immune healing after a heart attack and reduce future heart failure.

How similar studies have gone: Preliminary data in animals suggest a link between T-cell dynamics and heart repair, but translating this to humans remains a key challenge.

Where this research is happening

  • University of South Florida
    Tampa, United States
    Active

Researchers

  • Principal investigator: Ma, Yonggang — University of South Florida
  • Study coordinator: Ma, Yonggang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.